MARKET

FBIO

FBIO

Fortress Biotech Inc
NASDAQ
1.860
-0.010
-0.53%
After Hours: 1.861 +0.001 +0.06% 19:47 01/21 EST
OPEN
1.880
PREV CLOSE
1.870
HIGH
1.920
LOW
1.820
VOLUME
273.26K
TURNOVER
--
52 WEEK HIGH
2.890
52 WEEK LOW
1.355
MARKET CAP
51.35M
P/E (TTM)
-0.5265
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FBIO last week (0113-0117)?
Weekly Report · 1d ago
CORRECTION: Fortress Biotech's Cyprium Therapeutics Announces FDA Extended NDA Target Date For CUTX-101 To September 30, 2025; Sentynl Responsible For Development And Commercialization; Cyprium Retains Priority Review Voucher Rights, Eligible For Up To $129M Royalties And Milestones
Benzinga · 5d ago
Fortress Biotech Inc - FDA Extends Target Action Date For Cutx-101 NDA To September 30, 2025
Benzinga · 5d ago
FORTRESS BIOTECH INC - FDA EXTENDS TARGET ACTION DATE FOR CUTX-101 NDA TO SEPTEMBER 30, 2025
Reuters · 5d ago
BUZZ-Mustang Bio falls after announcement of reverse stock split
Reuters · 01/14 14:07
MUSTANG BIO INC - STOCK TO BEGIN TRADING ON SPLIT-ADJUSTED BASIS JAN 16, 2025
Reuters · 01/14 13:00
Weekly Report: what happened at FBIO last week (0106-0110)?
Weekly Report · 01/13 09:38
Fortress Biotech (FBIO) Gets a Buy from Roth MKM
TipRanks · 01/08 15:55
More
About FBIO
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has seven marketed prescription pharmaceutical products and over 25 programs in development at the Company, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Such product candidates span six market areas, including oncology, rare diseases and gene therapy. Its dermatology products include Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Exelderm and Luxamend. Its late stage product candidates include Cosibelimab (anti-PD-L1 antibody), DFD-29 (modified release oral minocycline for the treatment of rosacea), CUTX-101 (copper histidinate injection for Menkes disease), IV Tramadol, Olafertinib (also known as CK-101, EGFR inhibitor for EGFR mutation-positive NSCLC), CAEL-101 (monoclonal antibody for AL amyloidosis) and Triplex (cytomegalovirus (CMV) vaccine).

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIO stock methods without spending real money on the virtual paper trading platform.